• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

资源匮乏环境下的抗逆转录病毒治疗依从性

Antiretroviral adherence in a resource-poor setting.

作者信息

Orrell Catherine

机构信息

Desmond Tutu HIV Centre, IIDMM, Werner Beit Building-North, Medical School, Anzio Road, Observatory, Cape Town 7925, South Africa.

出版信息

Curr HIV/AIDS Rep. 2005 Nov;2(4):171-6. doi: 10.1007/s11904-005-0012-8.

DOI:10.1007/s11904-005-0012-8
PMID:16343374
Abstract

Adherence is key to successful antiretroviral therapy (ART). Many countries with increased HIV prevalence and the greatest need for ART have limited health resources. Recent assumptions that the adherence required for successful ART will not be achieved in resource-poor settings have led to calls for caution in expanded access programs. New studies from Africa refute this, showing excellent adherence and virologic outcomes. Major factors contributing to adherence or nonadherence are whether the drug is accessed for free or is self-funded, patient preparedness for use of ART, stigmatization related to being HIV-positive, and ease of use of regimen.

摘要

坚持服药是抗逆转录病毒疗法(ART)成功的关键。许多艾滋病毒感染率上升且最需要抗逆转录病毒疗法的国家,卫生资源有限。最近有人认为,在资源匮乏地区无法实现成功的抗逆转录病毒疗法所需的坚持服药,这导致人们呼吁在扩大治疗项目时要谨慎。非洲的新研究反驳了这一观点,显示出很高的坚持服药率和病毒学治疗效果。导致坚持服药或不坚持服药的主要因素包括药物是免费获得还是自费、患者对使用抗逆转录病毒疗法的准备情况、与艾滋病毒呈阳性相关的污名化以及治疗方案的易用性。

相似文献

1
Antiretroviral adherence in a resource-poor setting.资源匮乏环境下的抗逆转录病毒治疗依从性
Curr HIV/AIDS Rep. 2005 Nov;2(4):171-6. doi: 10.1007/s11904-005-0012-8.
2
Adherence is not a barrier to successful antiretroviral therapy in South Africa.在南非,坚持治疗并非成功进行抗逆转录病毒治疗的障碍。
AIDS. 2003 Jun 13;17(9):1369-75. doi: 10.1097/00002030-200306130-00011.
3
Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.通过识别南非二线抗逆转录病毒治疗失败高风险患者来预测三线抗逆转录病毒治疗的需求
AIDS Patient Care STDS. 2017 May;31(5):205-212. doi: 10.1089/apc.2016.0291. Epub 2017 Apr 26.
4
Doubts about DOT: antiretroviral therapy for resource-poor countries.对直接观察治疗的质疑:资源匮乏国家的抗逆转录病毒疗法。
AIDS. 2003 Jun 13;17(9):1383-7. doi: 10.1097/00002030-200306130-00013.
5
Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.针对南非约翰内斯堡接受二线抗逆转录病毒治疗失败的艾滋病毒感染者的强化依从性咨询。
Trop Med Int Health. 2016 Sep;21(9):1131-7. doi: 10.1111/tmi.12741. Epub 2016 Jul 7.
6
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.人类免疫缺陷病毒基因耐药性检测对治疗效果的影响研究。
Verh K Acad Geneeskd Belg. 2001;63(5):447-73.
7
Strategies to optimize HIV treatment outcomes in resource-limited settings.资源有限环境下优化 HIV 治疗效果的策略。
AIDS Rev. 2009 Oct-Dec;11(4):179-89.
8
Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities.中低收入国家抗逆转录病毒疗法的依从性和治疗保留率:现有知识状况和研究重点。
Curr Opin HIV AIDS. 2010 Jan;5(1):70-7. doi: 10.1097/COH.0b013e328333ad61.
9
Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.撒哈拉以南非洲和亚洲地区艾滋病毒抗逆转录病毒治疗的依从性:两个区域队列的比较分析。
J Int AIDS Soc. 2017 Mar 3;20(1):21218. doi: 10.7448/IAS.20.1.21218.
10
Adherence to HAART: Africans take medicines more faithfully than North Americans.坚持高效抗逆转录病毒治疗:非洲人比北美人更忠实地服药。
PLoS Med. 2007 Feb;4(2):e83. doi: 10.1371/journal.pmed.0040083.

引用本文的文献

1
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells.确定蛋白激酶C调节剂类HIV潜伏逆转剂对自然杀伤细胞的作用。
Pathog Immun. 2024 Apr 24;9(1):108-137. doi: 10.20411/pai.v9i1.673. eCollection 2024.
2
HIV-Positive Women Taking Lifelong Antiretroviral Therapy Report Better Adherence Than Women Taking Short-Course Prophylaxis During and After Pregnancy Under PMTCT Program Option A in Lusaka, Zambia.在赞比亚卢萨卡,接受艾滋病病毒阳性的妇女接受终身抗逆转录病毒治疗,在预防母婴传播(PMTCT)方案A下,在孕期及产后接受短期预防治疗的妇女相比,她们的治疗依从性更好。
Int J MCH AIDS. 2017;6(1):27-35. doi: 10.21106/ijma.164.
3

本文引用的文献

1
Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy.乌干达艾滋病毒呈阳性且自费购买治疗药物的患者对抗逆转录病毒疗法的依从性。
Int J STD AIDS. 2005 Jan;16(1):38-41. doi: 10.1258/0956462052932548.
2
Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults.高效抗逆转录病毒疗法对塞内加尔感染HIV-1的成年人的长期益处。
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):14-7. doi: 10.1097/00126334-200501010-00003.
3
Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa.
The effects of setarud on the immunological status of HIV-positive patients: Efficacy of a novel multi-herbal drug.
塞塔鲁德对HIV阳性患者免疫状态的影响:一种新型多草药药物的疗效。
Avicenna J Phytomed. 2017 May-Jun;7(3):232-241.
4
Sexual and reproductive health and human rights of women living with HIV.感染艾滋病毒妇女的性与生殖健康及人权
J Int AIDS Soc. 2015 Dec 1;18(6Suppl 5):20834. doi: 10.7448/IAS.18.6.20834. eCollection 2015.
5
Factors associated with loss to follow-up among women in Option B+ PMTCT programme in northeast Ethiopia: a retrospective cohort study.埃塞俄比亚东北部B+预防母婴传播项目中女性失访的相关因素:一项回顾性队列研究
J Int AIDS Soc. 2016 Mar 21;19(1):20662. doi: 10.7448/IAS.19.1.20662. eCollection 2016.
6
Fundamental concerns of women living with HIV around the implementation of Option B+.感染艾滋病毒的女性对“B+方案”实施情况的基本关切。
J Int AIDS Soc. 2015 Dec 1;18(Suppl 5):20286. doi: 10.7448/IAS.18.6.20286. eCollection 2015.
7
A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa.一项关于南非患者坚持联合抗逆转录病毒治疗动机的定性研究。
AIDS Patient Care STDS. 2015 May;29(5):299-306. doi: 10.1089/apc.2014.0293. Epub 2015 Feb 18.
8
Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi.实施与运营研究:“B+方案”对马拉维利隆圭产前预防母婴传播流程的影响
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):e77-83. doi: 10.1097/QAI.0000000000000517.
9
The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa.药丸计数与自我报告的依从性相结合,是南非成年人一线抗逆转录病毒治疗失败的有力预测指标。
Curr HIV Res. 2014;12(5):366-75. doi: 10.2174/1570162x1205141121102501.
10
Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).迈向消除母婴传播艾滋病毒:马拉维为孕妇启动终身抗逆转录病毒治疗的不同护理模式的成效(选项B+)
J Int AIDS Soc. 2014 Jul 28;17(1):18994. doi: 10.7448/IAS.17.1.18994. eCollection 2014.
南非索韦托地区HIV感染成人对抗逆转录病毒疗法的依从性
AIDS Res Hum Retroviruses. 2004 Oct;20(10):1053-6. doi: 10.1089/aid.2004.20.1053.
4
Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model.在资源匮乏地区监测抗逆转录病毒疗法的疗效:马拉维模式。
Trans R Soc Trop Med Hyg. 2004 Dec;98(12):695-701. doi: 10.1016/j.trstmh.2004.05.002.
5
Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality.巴西的高效抗逆转录病毒疗法:社会不平等背景下普及治疗的挑战。
Rev Panam Salud Publica. 2004 Aug;16(2):78-83. doi: 10.1590/s1020-49892004000800002.
6
Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.一项针对感染艾滋病毒儿童及其感染父母的公共部门抗逆转录病毒治疗项目的初步经验。
S Afr Med J. 2004 Aug;94(8):643-6.
7
Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa.促进抗逆转录病毒疗法的依从性:南非开普敦凯伊利沙镇一家基层医疗诊所的经验
AIDS. 2004 Jun;18 Suppl 3:S27-31. doi: 10.1097/00002030-200406003-00006.
8
Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience.在资源有限的环境中扩大艾滋病毒治疗项目:海地农村的经验。
AIDS. 2004 Jun;18 Suppl 3:S21-5. doi: 10.1097/00002030-200406003-00005.
9
Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.多项经过验证的依从性测量方法表明,在资源有限的环境中,对通用型艾滋病毒抗逆转录病毒疗法的依从性很高。
J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1100-2. doi: 10.1097/00126334-200408150-00014.
10
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.奈韦拉平、司他夫定和拉米夫定通用固定剂量组合用于喀麦隆HIV-1感染成人的有效性和安全性:开放标签多中心试验。
Lancet. 2004;364(9428):29-34. doi: 10.1016/S0140-6736(04)16586-0.